PINDOLOL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Pindolol, and what generic alternatives are available?
Pindolol is a drug marketed by Ani Pharms, Aurobindo Pharma Usa, Bayshore Pharms Llc, Cosette, Mylan Pharms Inc, Nostrum Labs, Nostrum Labs Inc, Purepac Pharm, Sun Pharm Industries, Watson Labs, and Zydus Pharms. and is included in fourteen NDAs.
The generic ingredient in PINDOLOL is pindolol. There are eleven drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the pindolol profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Pindolol
A generic version of PINDOLOL was approved as pindolol by AUROBINDO PHARMA USA on September 3rd, 1992.
Summary for PINDOLOL
US Patents: | 0 |
Applicants: | 11 |
NDAs: | 14 |
Finished Product Suppliers / Packagers: | 9 |
Raw Ingredient (Bulk) Api Vendors: | 78 |
Clinical Trials: | 16 |
Patent Applications: | 4,287 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for PINDOLOL |
DailyMed Link: | PINDOLOL at DailyMed |
Recent Clinical Trials for PINDOLOL
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Rawalpindi Medical College | Phase 3 |
Scotmann Pharmaceuticals | Phase 3 |
National Institute on Aging (NIA) | Phase 4 |
Pharmacology for PINDOLOL
Drug Class | beta-Adrenergic Blocker |
Mechanism of Action | Adrenergic beta-Antagonists |
Medical Subject Heading (MeSH) Categories for PINDOLOL
Anatomical Therapeutic Chemical (ATC) Classes for PINDOLOL
US Patents and Regulatory Information for PINDOLOL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ani Pharms | PINDOLOL | pindolol | TABLET;ORAL | 073609-002 | Mar 29, 1993 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Nostrum Labs Inc | PINDOLOL | pindolol | TABLET;ORAL | 205415-002 | Jan 13, 2016 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Watson Labs | PINDOLOL | pindolol | TABLET;ORAL | 074437-002 | Feb 27, 1995 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Cosette | PINDOLOL | pindolol | TABLET;ORAL | 073661-001 | Oct 31, 1993 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Aurobindo Pharma Usa | PINDOLOL | pindolol | TABLET;ORAL | 074019-002 | Sep 3, 1992 | AB | RX | No | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Cosette | PINDOLOL | pindolol | TABLET;ORAL | 074123-002 | Apr 17, 1997 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |